Sentences with phrase «clinical research partnership»

Not exact matches

On Thursday, the company announced it had struck 15 separate trade deals in China, one of the most notable being a partnership with Tencent Holdings to advance the use of artificial intelligence to support research and clinical decision making.

The hospital is a major pediatric clinical research center and a teaching hospital in partnership with the University of California and San Diego School of Medicine.

Lemak Health is instrumental in guiding and providing clinical resources and expertise to YSA in all of our clinical, education and research partnerships and programs.

Additionally, through our exclusive partnership with Binghamton University we will help forward the clinical body of research on CBD and other cannabinoids derived from hemp.

Kramer, who from 1993 to 1996 was vice president and U.S. director of clinical research at Burroughs Wellcome & Co. (which later merged with Glaxo Inc., now GlaxoSmithKline), says defining roles and expectations at the beginning of a partnership will save grief down the road.

Through a unique partnership with community organization My Brother's Keeper, Inc., headquartered in Jackson, the CETC has established the Mississippi INBRE Service Scholars summer internship aimed at introducing students from Mississippi's primarily undergraduate colleges and universities to public health and health disparities education, clinical practice, and research.

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreaticclinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreaticClinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cancer.

These statistically significant and clinically meaningful improvements in overall response and survival rates resulted from a phase Ib / II clinical study performed at the HonorHealth Research Institute, a partnership of HonorHealth and TGen.

This pilot clinical trial began in 2013 through a partnership between the HonorHealth Research Institute and TGen.

Similarly, the NCI Formulary, a partnership between NCI and biotechnology and pharmaceutical companies to improve access to otherwise proprietary experimental drugs, has so far enabled about a dozen pharmaceutical and biotech companies to work through thorny negotiations on intellectual property, licensing, and other issues, to speed research and clinical testing.

About the Anna - Maria Kellen Clinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innClinical Accelerator The Anna - Maria Kellen Clinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innClinical Accelerator, the clinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innclinical research program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch program of the Cancer Research Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innResearch Institute, leverages CRI's partnerships with nonprofit organizations, pharmaceutical and biotech companies, and academic research and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch and treatment centers worldwide, to provide scientists and clinicians with expertise in cancer immunotherapy access to resources they need to advance ambitious clinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innclinical and translational research ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innresearch ideas, while simulataneous solving for competitive and regulatory hurdles that would otherwise impede innovation.

NEW YORK AND SAN DIEGO (Sept. 3, 2014)-- The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX - 2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.

Oncology research and clinical advancements often require financial partnerships and collaborations between industry and oncology physicians and researchers.

CRI will continue to forge new partnerships, connect people, and fund clinical trials in order to advance cancer research.

Whitaker will be a key player in implementing the Urban Health Initiative (UHI), the University of Chicago Medical Center's long - range plan to build and maintain a network of partnerships and mutually beneficial relationships throughout the community to provide superior care for patients, advance community - based clinical research and broaden medical education.

Models of interinstitutional partnerships between research - intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) Consortium.

Honored to be selected in partnership with Dr. James Shapiro, for @StemCellNetwork's Clinical Trials Program for innovative regenerative medicine research that could help translate discoveries into better health.

The Olivia Newton - John Cancer Research Institute is recruiting Group Leaders with established track records in fundamental cancer research to strengthen our clinical and laboratory partnership pResearch Institute is recruiting Group Leaders with established track records in fundamental cancer research to strengthen our clinical and laboratory partnership presearch to strengthen our clinical and laboratory partnership programs.

We support a broad portfolio of clinical and translational research through response mode funding, partnership initiatives and investments in clinical infrastructure.

4/7/2008 From Bench to Bedside in One Year: Stem Cell Research Leads to Potential New Therapy for Rare Blood Disorder A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... More...

Dr. Novikov's lecture is a part of the Translational Research In Progress (TRIP) Seminar series hosted by the Clinical and Translational Science Institute, an interdisciplinary partnership among New York University, the NYU Langone Medical Center, and the New York City Health and Hospitals Corporation.

In partnership with the University of Pittsburgh Cancer Institute, it maintains rigorous standards in clinical and research quality, consistency, and outcomes at more than 50 outpatient cancer centers.

As one of six GRA universities, Emory has benefited from this unique partnership in numerous ways: through its 11 Eminent Scholars, multidisciplinary university and industry collaborations, and support for research in vaccines, nanomedicine, transplantation, neurosciences, pediatrics, biomedical engineering, clinical research, and drug discovery.

Collins asked that his visit focus on â $ œhow CTSAs are enabling science.â $ It was an opportunity for the ACTSI, a partnership among Emory, Morehouse School of Medicine, Georgia Institute of Technology and others, including Children's Healthcare of Atlanta, Georgia Research Alliance, Georgia BIO, Kaiser Permanente, CDC, the Atlanta VA Medical Center and the Grady Health System, to showcase the unique contributions the ACTSI makes to enabling clinical and translational rResearch Alliance, Georgia BIO, Kaiser Permanente, CDC, the Atlanta VA Medical Center and the Grady Health System, to showcase the unique contributions the ACTSI makes to enabling clinical and translational researchresearch.

Dr Ian Walker, licensing manager for clinical partnerships at Cancer Research Technology, said: «It is fantastic to see a drug from our CDP programme progressing toward a clinical trial to be tested as a potential new treatment for cancer patients.

Clinical Development Partnerships (CDP) is a joint initiative between Cancer Research UK and Cancer Research Technology, the charity's development and commercialisation arm.

«This collaboration is what great partnerships look like — uniting CRI's cancer immunology expertise with the clinical research expertise and global footprint at CCTG, which I've observed is the fastest and most effective cooperative group worldwide.

He further notes that there is ``... significant discordance between preclinical findings and clinical results» and ``... inefficient partnerships between academia and industry,» two challenges that must be addressed if academic research is to yield maximum clinical benefit and attain the ultimate goal of saving patients» lives.

First, in 2001, CRI formed a partnership with the Ludwig Institute for Cancer Research to develop the Cancer Vaccine Collaborative (CVC)-- a centralized, academic, global network of clinical trial sites, immune monitoring laboratories, and clinic - grade, GMP cancer vaccine production facilities.

Last year we spent # 386 million on your research, funding 4,000 researchers plus infrastructure and partnerships across the full breadth of basic, translational, clinical and population research.

USAID's investments have been put to work by IAVI to enable both AIDS vaccine research and the cultivation of scientific and technical capacity at clinical research centers in developing countries that conduct vaccine trials in partnership with the organization.

Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer - specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance.

Current partnerships, including articulation agreements, enrich our student experience, expose others to the philosophies and practices of integrative health, and forward the field through education, research, and clinical practice.

National University of Natural Medicine (NUNM) today announced it has formed an educational partnership with Saint Luke's Hospital in Kansas City, Missouri, to collaborate in the delivery of clinical and community education nutrition workshops and research in the Midwest.

Three new videos are available this week on AACTE's Research - to - Practice Spotlight Series highlighting clinical preparation and partnerships of the University of Nevada, Las Vegas (UNLV) College of Education.

Three new videos are available this week in AACTE's Research - to - Practice Spotlight Series highlighting clinical preparation and partnerships of the University of Nevada, Las Vegas (UNLV) College of Education.

Four new videos are available this week in AACTE's Research - to - Practice Spotlight Series highlighting clinical preparation and partnerships of the Butler University (IN) College of Education.

This spring, AACTE will present a new webinar series, «Leveraging Community Resources to Strengthen Clinical Practice for New Principals,» supported by The Wallace Foundation as part of the Association's ongoing partnership to disseminate the latest research and practice innovations in principal preparation.

In clinical practice she has participated in research study partnerships with Hills Pet nutrition and Vetraxx.

Our close physical and intellectual partnership with clinical and basic researchers across a wide variety of disciplines here at the University fosters research that would not be possible if we were a remote entity.

Understanding the Impact of Trauma and Urban Poverty on Family Systems: Risks, Resilience, and Interventions (2010) K. Collins, K. Connors, A. Donohue, S. Gardner, E. Goldblatt, A. Hayward, L. Kiser, F. Strieder, and E. Thompson This white paper reviews the clinical and research literatures on the impact of trauma — within the context of urban poverty — on the family system, including the individual child or adult; adult intimate partnerships; parent - child, siblings, and intergenerational relationships; and the family as a whole.

Inala Indigenous Health Service Clinical Director Professor Noel Hayman said working in partnership with Menzies School of Health Research for the B.strong training program was crucial for its success.